Skip to main content
Midas Edge

I-Mab

For the period ended Dec 31, 2024. Filed Apr 3, 2025.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2024 · Filed Apr 3, 2025

NBP$0.91+0.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

CODE OF ETHICS

ITEM 16B. CODE OF ETHICS

We have in place a code of business conduct and ethics that applies to our directors, officers and employees, which was most recently amended and restated in December 2024. We have posted a copy of our code of business conduct and ethics on our website at http://ir.i-mabbiopharma.com/, and a copy of our code of business conduct and ethics is filed herewith as an exhibit.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.